Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
71.9M
-
Number of holders
-
38
-
Total 13F shares, excl. options
-
17.5M
-
Shares change
-
-1.4M
-
Total reported value, excl. options
-
$118M
-
Value change
-
-$9.43M
-
Number of buys
-
18
-
Number of sells
-
-15
-
Price
-
$6.75
Significant Holders of SINOVAC BIOTECH LTD. - Common Shares (SVA) as of Q2 2017
43 filings reported holding SVA - SINOVAC BIOTECH LTD. - Common Shares as of Q2 2017.
SINOVAC BIOTECH LTD. - Common Shares (SVA) has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.5M shares
of 71.9M outstanding shares and own 24.35% of the company stock.
Largest 10 shareholders include SAIF Advisors Ltd (10.8M shares), ORBIMED ADVISORS LLC (2.67M shares), RENAISSANCE TECHNOLOGIES LLC (1.81M shares), MORGAN STANLEY (1M shares), GLG Partners LP (283K shares), Eqis Capital Management, Inc. (157K shares), Invesco Ltd. (110K shares), WOLVERINE ASSET MANAGEMENT LLC (78.9K shares), MILLENNIUM MANAGEMENT LLC (65.4K shares), and TWO SIGMA INVESTMENTS, LP (62.3K shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.